文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

视网膜神经节细胞结构和功能在青光眼中的作用。

The Role of Retinal Ganglion Cell Structure and Function in Glaucoma.

机构信息

Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.

出版信息

Cells. 2023 Dec 8;12(24):2797. doi: 10.3390/cells12242797.


DOI:10.3390/cells12242797
PMID:38132117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10741833/
Abstract

Glaucoma, a leading cause of irreversible blindness globally, primarily affects retinal ganglion cells (RGCs). This review dives into the anatomy of RGC subtypes, covering the different underlying theoretical mechanisms that lead to RGC susceptibility in glaucoma, including mechanical, vascular, excitotoxicity, and neurotrophic factor deficiency, as well as oxidative stress and inflammation. Furthermore, we examined numerous imaging methods and functional assessments to gain insight into RGC health. Finally, we investigated the current possible neuroprotective targets for RGCs that could help with future glaucoma research and management.

摘要

青光眼是全球范围内导致不可逆性失明的主要原因,主要影响视网膜神经节细胞(RGCs)。本综述深入探讨了 RGC 亚型的解剖结构,涵盖了导致青光眼 RGC 易感性的不同潜在理论机制,包括机械性、血管性、兴奋性毒性和神经营养因子缺乏以及氧化应激和炎症。此外,我们还研究了许多成像方法和功能评估方法,以深入了解 RGC 的健康状况。最后,我们研究了目前 RGC 可能的神经保护靶标,这有助于未来的青光眼研究和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51f2/10741833/c4b886a12545/cells-12-02797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51f2/10741833/c4b886a12545/cells-12-02797-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51f2/10741833/c4b886a12545/cells-12-02797-g001.jpg

相似文献

[1]
The Role of Retinal Ganglion Cell Structure and Function in Glaucoma.

Cells. 2023-12-8

[2]
Functional analysis of mesencephalic astrocyte-derived neurotrophic factor in retinal ganglion cells under oxidative stress.

Cell Biochem Funct. 2021-1

[3]
Natural compounds and retinal ganglion cell neuroprotection.

Prog Brain Res. 2015

[4]
Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma.

Cytotherapy. 2016-2-17

[5]
Neuroprotection in glaucoma - Is there a future role?

Exp Eye Res. 2010-8-26

[6]
An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.

Invest Ophthalmol Vis Sci. 2010-3-31

[7]
Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model.

J Neurosci. 2019-1-17

[8]
The neuroprotective effect of melatonin in glutamate excitotoxicity of R28 cells and mouse retinal ganglion cells.

Front Endocrinol (Lausanne). 2022

[9]
Upregulation of the endothelin A (ET) receptor and its association with neurodegeneration in a rodent model of glaucoma.

BMC Neurosci. 2017-3-1

[10]
Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials.

Cell Mol Neurobiol. 2023-10

引用本文的文献

[1]
DHRS9 promotes malignant progression of ovarian cancer through SQSTM1.

J Cancer Res Clin Oncol. 2025-8-27

[2]
Assessment of Kynurenine Pathway Enzyme Activity in Ocular Diseases: Associations with Cataract, Diabetes, Glaucoma, and Pseudoexfoliation Syndrome.

J Clin Med. 2025-6-26

[3]
Targeting Senescence, Oxidative Stress, and Inflammation: Quercetin-Based Strategies for Ocular Diseases in Older Adults.

Clin Interv Aging. 2025-6-7

[4]
Damage and repair in retinal degenerative diseases: Molecular basis through clinical translation.

Neural Regen Res. 2026-4-1

[5]
miRNA changes associated with differentiation of human embryonic stem cells into human retinal ganglion cells.

Sci Rep. 2024-12-30

[6]
Review: Neuroprotective Nanocarriers in Glaucoma.

Pharmaceuticals (Basel). 2024-9-10

[7]
Systematic bibliometric and visualized analysis of research hotspots and trends on the application of artificial intelligence in glaucoma from 2013 to 2022.

Int J Ophthalmol. 2024-9-18

[8]
Minocycline Administration Does Not Have an Effect on Retinal Ganglion Cell Survival in a Murine Model of Ocular Hypertension.

Aging Dis. 2024-10-1

本文引用的文献

[1]
The Association between Vascular Abnormalities and Glaucoma-What Comes First?

Int J Mol Sci. 2023-8-25

[2]
Cell-Based Therapies for Glaucoma.

Transl Vis Sci Technol. 2023-7-3

[3]
Pathologically high intraocular pressure induces mitochondrial dysfunction through Drp1 and leads to retinal ganglion cell PANoptosis in glaucoma.

Redox Biol. 2023-6

[4]
Clinical Applications of Artificial Intelligence in Glaucoma.

J Ophthalmic Vis Res. 2023-2-21

[5]
Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases.

Rev Neurosci. 2023-4-25

[6]
Elevated endothelin-1 levels as risk factor for an impaired ocular blood flow measured by OCT-A in glaucoma.

Sci Rep. 2022-7-12

[7]
Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.

Front Pharmacol. 2022-5-20

[8]
Retinal Glutamate Neurotransmission: From Physiology to Pathophysiological Mechanisms of Retinal Ganglion Cell Degeneration.

Life (Basel). 2022-4-25

[9]
The Role of Axonal Transport in Glaucoma.

Int J Mol Sci. 2022-4-1

[10]
NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function.

Mol Ther. 2022-4-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索